Effects of drugs on cornea, conjunctiva, and lids.
D000328:Adult; D000700:Analgesics / Q000009:adverse effects; D000779:Anesthetics, Local / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D001152:Arsenicals / Q000009:adverse effects; D003228:Conjunctiva / Q000187:drug effects*; D003300:Copper / Q000009:adverse effects; D003315:Cornea / Q000187:drug effects*; D004112:Dimercaprol / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005128:Eye Diseases / Q000139:chemically induced*; D005141:Eyelid Diseases / Q000139:chemically induced*; D005143:Eyelids / Q000187:drug effects*; D005260:Female; D006046:Gold / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007454:Iodides / Q000009:adverse effects; D008297:Male; D008628:Mercury / Q000009:adverse effects; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D012834:Silver / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013566:Sympathomimetics / Q000009:adverse effects
D000700:Analgesics; D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000962:Antimalarials; D001152:Arsenicals; D006993:Hypnotics and Sedatives; D007454:Iodides; D009883:Ophthalmic Solutions; D010276:Parasympatholytics; D010277:Parasympathomimetics; D010640:Phenothiazines; D013449:Sulfonamides; D013566:Sympathomimetics; D004112:Dimercaprol; D012834:Silver; D006046:Gold; D003300:Copper; D008628:Mercury